ONEVoice, a landmark survey funded by the Muscular Dystrophy Association (MDA) and conducted by Edge Research, has identified key areas of concern among more than 3,000 respondents – 2,430 adults with neuromuscular disease and 932 caregivers/family members – as well...
Flower Orthopedics is pleased to announce the results of a 14-month, multi-center, prospective trial comparing the use of the FlowerCube system to traditional implants in first metatarsal phalangeal joint fusions in 71 consecutive patients. This study, led by Dr. John...
– AGB101 is the first investigational therapeutic that targets the reduction of hippocampal overactivity. – The study evaluates both Primary and Secondary Endpoints to measure cognitive and functional efficacy. – Secondary imaging endpoints will...
Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today it had entered into a collaboration agreement with Nassau based Foot and Ankle International (Bahamas) to conduct two Phase 2 cDFU clinical trial for its topically...
-PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced PharmaCyte’s partner, Austrianova, has...
Email
Text